Friedemann Paul
Experimental and Clinical Research Center
Max Delbrueck Center for Molecular Medicine and Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health
Friedemann Paul has not added Biography.
If you are Friedemann Paul and would like to personalize this page please email our Author Liaison for assistance.
Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography.
Multiple sclerosis (Houndmills, Basingstoke, England) May, 2015 | Pubmed ID: 25662342
Sleep Disorders Reduce Health-Related Quality of Life in Multiple Sclerosis (Nottingham Health Profile Data in Patients with Multiple Sclerosis).
International journal of molecular sciences Jul, 2015 | Pubmed ID: 26197315
[Current immunotherapy of multiple sclerosis].
Der Nervenarzt Aug, 2015 | Pubmed ID: 26253589
Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis.
Journal of neuroinflammation Oct, 2015 | Pubmed ID: 26521232
Distinct functionality of neutrophils in multiple sclerosis and neuromyelitis optica.
Multiple sclerosis (Houndmills, Basingstoke, England) Feb, 2016 | Pubmed ID: 26540731
Quantitative motor assessment of muscular weakness in myasthenia gravis: a pilot study.
BMC neurology Dec, 2015 | Pubmed ID: 26701600
Power estimation for non-standardized multisite studies.
NeuroImage 07, 2016 | Pubmed ID: 27039700
Neuromyelitis optica does not impact periventricular venous density versus healthy controls: a 7.0 Tesla MRI clinical study.
Magma (New York, N.Y.) Jun, 2016 | Pubmed ID: 27072685
What is the future of proof of concept studies in multiple sclerosis?
The Lancet. Neurology 10, 2016 | Pubmed ID: 27567241
Synapsin-antibodies in psychiatric and neurological disorders: Prevalence and clinical findings.
Brain, behavior, and immunity Nov, 2017 | Pubmed ID: 28733081
Functional connectivity of large-scale brain networks in patients with anti-NMDA receptor encephalitis: an observational study.
The lancet. Psychiatry 10, 2017 | Pubmed ID: 28882707
[Optical coherence tomography in neuromyelitis optica spectrum disorders].
Der Nervenarzt Dec, 2017 | Pubmed ID: 29119196
What should a person with relapsing-remitting multiple sclerosis know? - Focus group and survey data of a risk knowledge questionnaire (RIKNO 2.0).
Multiple sclerosis and related disorders Nov, 2017 | Pubmed ID: 29141808
Magnetic resonance imaging findings at the first episode of acute optic neuritis.
Multiple sclerosis and related disorders Feb, 2018 | Pubmed ID: 29291481
MRI-Based Methods for Spinal Cord Atrophy Evaluation: A Comparison of Cervical Cord Cross-Sectional Area, Cervical Cord Volume, and Full Spinal Cord Volume in Patients with Aquaporin-4 Antibody Seropositive Neuromyelitis Optica Spectrum Disorders.
AJNR. American journal of neuroradiology 07, 2018 | Pubmed ID: 29748202
Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study.
Journal of neurology, neurosurgery, and psychiatry 12, 2018 | Pubmed ID: 29921610
Comparison of probabilistic tractography and tract-based spatial statistics for assessing optic radiation damage in patients with autoimmune inflammatory disorders of the central nervous system.
NeuroImage. Clinical , 2018 | Pubmed ID: 29984162
Venoplasty in MS: Therapeutic intervention without any evidence.
Neurology 10, 2018 | Pubmed ID: 30266888
Optic chiasm measurements may be useful markers of anterior optic pathway degeneration in neuromyelitis optica spectrum disorders.
European radiology Sep, 2020 | Pubmed ID: 32335748
Cohort profile: a collaborative multicentre study of retinal optical coherence tomography in 539 patients with neuromyelitis optica spectrum disorders (CROCTINO).
BMJ open 10, 2020 | Pubmed ID: 33122310
Max Delbrueck Center for Molecular Medicine and Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health
Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Sonia Waiczies*,1,
Antje Els*,1,
Joseph Kuchling*,2,3,4,
Karin Markenroth Bloch5,
Anna Pankowska6,7,
Helmar Waiczies8,
Carl Herrmann1,
Claudia Chien2,3,
Carsten Finke4,9,
Friedemann Paul2,3,4,
Thoralf Niendorf1,2,8
1Berlin Ultrahigh Field Facility (B.U.F.F.), Max Delbrück Center for Molecular Medicine in the Helmholtz Association,
2Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health,
3NeuroCure Clinical Research Center, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health,
4Department of Neurology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health,
5The Swedish National 7T Facility, Lund University Bioimaging Center, Lund University,
6Department of Radiography, Medical University of Lublin,
7ECOTECH-COMPLEX, Maria Curie-Skłodowska University,
8, MRI.TOOLS GmbH,
9Berlin School of Mind and Brain, Humboldt-Universität zu Berlin
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved